Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in J Infect

Retrieve available abstracts of 85 articles:
HTML format

Single Articles

    February 2021
  1. LIU Q, Fang X, Chen X, Dai X, et al
    Letter to the editor: Application of the Xpert MTB/RIF technology in the diagnosis and treatment of osteoarticular tuberculosis.
    J Infect. 2021 Feb 20. pii: S0163-4453(21)00092.

  2. WANG G, Jiang G, Jing W, Zong Z, et al
    Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: a subsequent study of a national survey.
    J Infect. 2021 Feb 5. pii: S0163-4453(21)00055.
    PubMed     Abstract available

    December 2020
  3. IZZARD A, Wilders S, Smith C, Wickers M, et al
    Improved treatment completion for Tuberculosis patients: the case for a dedicated social care team.
    J Infect. 2020 Dec 23. pii: S0163-4453(20)30780.
    PubMed     Abstract available

  4. MARINE E, Loic H, Christelle GC, Pierre-Louis N, et al
    Improving tuberculosis management in prisons: impact of a rapid molecular point-of-care test.
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30764.
    PubMed     Abstract available

  5. ADANKWAH E, Nausch N, Minadzi D, Abass MK, et al
    Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosis.
    J Infect. 2020 Dec 2. pii: S0163-4453(20)30729.
    PubMed     Abstract available

  6. LIU XH, Xia L, Song B, Wang H, et al
    Stool-based Xpert MTB/RIF Ultra Assay as a tool for detecting pulmonary tuberculosis in children with abnormal chest imaging: a prospective cohort study.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30727.
    PubMed     Abstract available

    November 2020
  7. VAN ZYL CW, Loots DT, Solomons R, van Reenen M, et al
    Metabolic characterization of tuberculous meningitis in a South African paediatric population using (1)H NMR metabolomics.
    J Infect. 2020;81:743-752.
    PubMed     Abstract available

    September 2020
  8. SUDBURY EL, Clifford V, Messina NL, Song R, et al
    Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.
    J Infect. 2020 Sep 29. pii: S0163-4453(20)30631.
    PubMed     Abstract available

    August 2020
  9. SHI CL, Han P, Tang PJ, Chen MM, et al
    Clinical Metagenomic Sequencing for etiological diagnosis in pulmonary tuberculosis suspects.
    J Infect. 2020 Aug 5. pii: S0163-4453(20)30537.
    PubMed     Abstract available

  10. CAPOCCI SJ, Sewell J, Smith C, Cropley I, et al
    Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting.
    J Infect. 2020;81:289-296.
    PubMed     Abstract available

    July 2020
  11. KOMIYA K, Yamasue M, Takahashi O, Hiramatsu K, et al
    The COVID-19 pandemic and the true incidence of tuberculosis in Japan.
    J Infect. 2020 Jul 7. pii: S0163-4453(20)30462.

    June 2020
  12. KIM H, Kim SH, Jung JH, Kim MJ, et al
    The usefulness of quantitative interferon-gamma releasing assay response for predicting active tuberculosis in kidney transplant recipients: a quasi-experimental study.
    J Infect. 2020 Jun 28. pii: S0163-4453(20)30452.
    PubMed     Abstract available

  13. MCGUIRE E, Rajagopal S, Vaikanthanathan T, Krutikov M, et al
    Extraspinal Articular Tuberculosis: an 11-year Retrospective Study of Demographic Features and Clinical Outcomes in East London.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30422.
    PubMed     Abstract available

  14. LAI CC, Yu WL
    The COVID-19 Pandemic and Tuberculosis in Taiwan.
    J Infect. 2020 Jun 10. pii: S0163-4453(20)30397.

    May 2020
  15. ZHOU X, Zhang L, Lie L, Zhang Z, et al
    MxA suppresses TAK1-IKKalpha/beta-NF-kappaB mediated inflammatory cytokine production to facilitate Mycobacterium tuberculosis infection.
    J Infect. 2020 May 20. pii: S0163-4453(20)30286.
    PubMed     Abstract available

    April 2020
  16. LUO Y, Tang G, Lin Q, Mao L, et al
    Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.
    J Infect. 2020 Apr 30. pii: S0163-4453(20)30264.
    PubMed     Abstract available

  17. ESTEVEZ O, Anibarro L, Garet E, Martinez A, et al
    Multi-parameter flow cytometry immunophenotyping distinguishes different stages of tuberculosis infection.
    J Infect. 2020 Apr 21. pii: S0163-4453(20)30218.
    PubMed     Abstract available

  18. HO J, Bokil NJ, Nguyen PTB, Nguyen TA, et al
    A Transcriptional Blood Signature Distinguishes Early Tuberculosis Disease from Latent Tuberculosis Infection and Uninfected Individuals in a Vietnamese Cohort.
    J Infect. 2020 Apr 21. pii: S0163-4453(20)30221.
    PubMed     Abstract available

    March 2020
  19. HU Y, Wen Z, Liu S, Cai Y, et al
    Ibrutinib Suppresses Intracellular Mycobacterium Tuberculosis Growth by Inducing Macrophage Autophagy.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30115.
    PubMed     Abstract available

    February 2020
  20. PETRUCCIOLI E, Chiacchio T, Navarra A, Vanini V, et al
    Effect of HIV-infection on QuantiFERON-Plus accuracy in patients with active tuberculosis and latent infection: QFT-Plus in HIV infected individuals.
    J Infect. 2020 Feb 22. pii: S0163-4453(20)30093.
    PubMed     Abstract available

  21. SUZUKAWA M, Takeda K, Akashi S, Asari I, et al
    Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis.
    J Infect. 2020 Feb 22. pii: S0163-4453(20)30092.
    PubMed     Abstract available

    January 2020
  22. PERETOKINA I, Krylova LY, Antonova OV, Kholina MS, et al
    Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates.
    J Infect. 2020 Jan 22. pii: S0163-4453(20)30031.
    PubMed     Abstract available

  23. ZHOU Y, Anthony R, Wang S, Ou X, et al
    The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives.
    J Infect. 2020 Jan 20. pii: S0163-4453(20)30022.
    PubMed     Abstract available

  24. CAMPRUBI D, Gomila A, Grijota-Camino MD, Soldevila L, et al
    Infectiousness of patients with smear-negative pulmonary tuberculosis, assessed by Real-time Polymerase Chain Reaction, Xpert(R)MTB/RIF.
    J Infect. 2020 Jan 16. pii: S0163-4453(20)30026.
    PubMed     Abstract available

    October 2019
  25. SEKYERE JO, Reta MA, Maningi NE, Fourie PB, et al
    Molecular Epidemiology, Diagnostics and Mechanisms of Antibiotic Resistance in Mycobacterium tuberculosis complex in Africa: A Systematic Review of Current Reports.
    J Infect. 2019 Oct 16. pii: S0163-4453(19)30316.
    PubMed     Abstract available

  26. KARMAKAR M, Trauer JM, Ascher DB, Denholm JT, et al
    Hyper transmission of Beijing lineage Mycobacterium tuberculosis: Systematic review and Meta-analysis.
    J Infect. 2019 Oct 1. pii: S0163-4453(19)30287.
    PubMed     Abstract available

    September 2019
  27. MANALAN K, Green N, Arnold A, Cooke GS, et al
    A cost comparison of amikacin therapy with bedaquiline, for drug-resistant tuberculosis in the UK.
    J Infect. 2019 Sep 21. pii: S0163-4453(19)30277.
    PubMed     Abstract available

    August 2019
  28. SOTGIU G, Saderi L, Petruccioli E, Aliberti S, et al
    QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis.
    J Infect. 2019 Aug 29. pii: S0163-4453(19)30258.
    PubMed     Abstract available

  29. LIU Z, Dong H, Wu B, Zhang M, et al
    Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings.
    J Infect. 2019 Aug 7. pii: S0163-4453(19)30243.
    PubMed     Abstract available

    July 2019
  30. MANNGO PM, Gutschmidt A, Snyders CI, Mutavhatsindi H, et al
    Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals.
    J Infect. 2019 Jul 15. pii: S0163-4453(19)30217.
    PubMed     Abstract available

    June 2019
  31. SUN Q, Wang S, Dong W, Jiang G, et al
    Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis.
    J Infect. 2019 Jun 14. pii: S0163-4453(19)30186.
    PubMed     Abstract available

    May 2019
  32. ZHANG M, He JQ
    Is the analysis sufficient? Letter to the Editor concerning the study of Prof. Wang titled "Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: A prospective cohort study".
    J Infect. 2019 May 28. pii: S0163-4453(19)30164.

  33. XU P, Tang P, Song H, Zhao J, et al
    The Incremental Value of Bronchoalveolar Lavage for the Diagnosis of Pulmonary Tuberculosis in a High-Burden Urban Setting.
    J Infect. 2019 May 14. pii: S0163-4453(19)30153.
    PubMed     Abstract available

    April 2019
  34. CHIACCHIO T, Petruccioli E, Vanini V, Cuzzi G, et al
    Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases.
    J Infect. 2019 Apr 11. pii: S0163-4453(19)30122.
    PubMed     Abstract available

  35. CAO Y, Yu C, Wu Y
    Incidence rate of depression as an adverse effect of multidrug-resistant tuberculosis treatment.
    J Infect. 2019 Apr 9. pii: S0163-4453(19)30113.

    March 2019
  36. MAHOMED S, Padayatchi N, Singh J, Naidoo K, et al
    Precision Medicine in Resistant Tuberculosis: Treat the correct patient, at the correct time, with the correct drug.
    J Infect. 2019 Mar 5. pii: S0163-4453(19)30075.
    PubMed     Abstract available

    February 2019
  37. WANG G, Wang S, Jiang G, Yang X, et al
    Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: a prospective cohort study.
    J Infect. 2019 Feb 20. pii: S0163-4453(19)30059.
    PubMed     Abstract available

    January 2019
  38. ZHANG H, Xin H, Wang D, Pan S, et al
    Serial Testing of Mycobacterium Tuberculosis Infection in Chinese Village Doctors by QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube and T-SPOT.TB.
    J Infect. 2019 Jan 30. pii: S0163-4453(19)30030.
    PubMed     Abstract available

  39. LEE MR, Chang CH, Chang LY, Chuang YC, et al
    CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status.
    J Infect. 2019 Jan 29. pii: S0163-4453(19)30028.
    PubMed     Abstract available

  40. HAMBLION EL, Burkitt A, Lalor MK, Anderson LF, et al
    Public Health Outcome of Tuberculosis Cluster Investigations, England 2010-2013.
    J Infect. 2019 Jan 14. pii: S0163-4453(19)30004.
    PubMed     Abstract available

    December 2018
  41. ZHAO HM, Du R, Li CL, Ji P, et al
    Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
    J Infect. 2018 Dec 5. pii: S0163-4453(18)30354.
    PubMed     Abstract available

  42. LUO J, Zhang M, Yan B, Li F, et al
    Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating among Mycobacterium tuberculosis infection.
    J Infect. 2018 Dec 5. pii: S0163-4453(18)30355.
    PubMed     Abstract available

    October 2018
  43. PRADIPTA IS, Forsman LD, Bruchfeld J, Hak E, et al
    Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis.
    J Infect. 2018 Oct 16. pii: S0163-4453(18)30307.
    PubMed     Abstract available

    September 2018
  44. SALI M, Buonsenso D, D'Alfonso P, De Maio F, et al
    Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.
    J Infect. 2018 Sep 26. pii: S0163-4453(18)30284.
    PubMed     Abstract available

    August 2018
  45. UHEL F, Corvaisier G, Poinsignon Y, Chirouze C, et al
    Mycobacterium tuberculosis prosthetic joint infections: a case series and literature review.
    J Infect. 2018 Aug 20. pii: S0163-4453(18)30253.
    PubMed     Abstract available

  46. HU Y, Yang Q, Dong J, Sun L, et al
    Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.
    J Infect. 2018 Aug 11. pii: S0163-4453(18)30251.
    PubMed     Abstract available

  47. BORISOV SE, D'Ambrosio L, Centis R, Tiberi S, et al
    Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline -containing regimens and undergoing adjunctive surgery.
    J Infect. 2018 Aug 7. pii: S0163-4453(18)30246.
    PubMed     Abstract available

    July 2018
  48. ALENE KA, Clements ACA, McBryde ES, Jaramillo E, et al
    Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.
    J Infect. 2018 Jul 20. pii: S0163-4453(18)30221.
    PubMed     Abstract available

  49. SABI I, Rachow A, Mapamba D, Clowes P, et al
    Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study.
    J Infect. 2018 Jul 20. pii: S0163-4453(18)30214.
    PubMed     Abstract available

  50. KOWADA A
    Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective.
    J Infect. 2018 Jul 12. pii: S0163-4453(18)30215.
    PubMed     Abstract available

    June 2018
  51. GAO Y, Zhang Z, Deng J, Mansjo M, et al
    Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
    J Infect. 2018 Jun 30. pii: S0163-4453(18)30192.
    PubMed     Abstract available

  52. TO KW, Kam KM, Chan DPC, Yip WH, et al
    Application of GeneXpert on bronchoalveolar lavage samples in the clinical management of patients suspicious of tuberculosis in an intermediate-burden setting.
    J Infect. 2018 Jun 28. pii: S0163-4453(18)30189.
    PubMed     Abstract available

  53. MORAN E, Baharani J, Dedicoat M, Robinson E, et al
    Renal failure and active tuberculosis in a high incidence UK city.
    J Infect. 2018 Jun 18. pii: S0163-4453(18)30179.
    PubMed     Abstract available

    May 2018
  54. PT P, B M, Fgj C
    BCG vaccination protects against infection with Mycobacterium tuberculosis ascertained by tuberculin skin testing.
    J Infect. 2018 May 17. pii: S0163-4453(18)30127.
    PubMed     Abstract available

  55. ANURADHA R, Munisankar S, Bhootra Y, Kumar NP, et al
    Malnutrition is associated with diminished baseline and mycobacterial antigen - stimulated chemokine responses in latent tuberculosis infection.
    J Infect. 2018 May 16. pii: S0163-4453(18)30143.
    PubMed     Abstract available

  56. KIM JY, Park JH, Kim MC, Cha HH, et al
    Combined IFN-gamma and TNF-alpha release assay for differentiating active tuberculosis from latent tuberculosis infection.
    J Infect. 2018 May 7. pii: S0163-4453(18)30116.
    PubMed     Abstract available

  57. ZHANG H, Xin H, Li X, Li H, et al
    Reversion of QuantiFERON-TB Gold In-Tube test in individuals with and without prophylactic treatment for latent tuberculosis infection: a Systematic Review and Meta-Analysis.
    J Infect. 2018 May 7. pii: S0163-4453(18)30112.
    PubMed     Abstract available

  58. E BS, Magda E, YuRong Y, Guangyu G, et al
    Identification of a plasma microRNA profile in untreated pulmonary tuberculosis patients that is modulated by anti-mycobacterial therapy.
    J Infect. 2018 May 7. pii: S0163-4453(18)30122.
    PubMed     Abstract available

    April 2018
  59. NGUYEN DTM, Graviss EA
    Development and validation of a prognostic score to predict tuberculosis mortality.
    J Infect. 2018 Apr 9. pii: S0163-4453(18)30062.
    PubMed     Abstract available

    January 2018
  60. XU C, Pang Y, Li R, Ruan Y, et al
    Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China.
    J Infect. 2018 Jan 25. pii: S0163-4453(18)30025.
    PubMed     Abstract available

    November 2017
  61. LIU Y, Li X, Liu W, Liu Y, et al
    IL-6 release of Rv0183 antigen-stimulated whole blood is a potential biomarker for active tuberculosis patients.
    J Infect. 2017 Nov 24. pii: S0163-4453(17)30376.
    PubMed     Abstract available

    October 2017
  62. ROYCROFT E, O'Toole RF, Fitzgibbon MM, Montgomery L, et al
    Molecular epidemiology of multi- and extensively-drug-resistant Mycobacterium tuberculosis in Ireland, 2001-2014.
    J Infect. 2017 Oct 12. pii: S0163-4453(17)30315.
    PubMed     Abstract available

    September 2017
  63. FRANCISCO NM, Fang YM, Ding L, Feng S, et al
    Diagnostic accuracy of a selected signature gene set that discriminates active pulmonary tuberculosis and other pulmonary diseases.
    J Infect. 2017 Sep 20. pii: S0163-4453(17)30304.
    PubMed     Abstract available

  64. SHAH R, Nabiswa H, Okinda N, Revathi G, et al
    The Diagnostic Accuracy Of Determine Tb Lam Antigen In Detection Of Extra Pulmonary Tuberculosis (Eptb).
    J Infect. 2017 Sep 4. pii: S0163-4453(17)30268.

    August 2017
  65. PANG Y, Lu J, Huo F, Ma Y, et al
    Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: a five-year review.
    J Infect. 2017 Aug 10. pii: S0163-4453(17)30262.
    PubMed     Abstract available

  66. TEIXEIRA RC, Rodriguez M, Jimenez de Romero N, Bruins M, et al
    The potential of a portable, point-of-care electronic nose to diagnose tuberculosis.
    J Infect. 2017 Aug 10. pii: S0163-4453(17)30260.
    PubMed     Abstract available

  67. RUFAI SB, Singh A, Singh J, Kumar P, et al
    Diagnostic usefulness of Xpert MTB/RIF assay for detection of tuberculous meningitis using cerebrospinal fluid.
    J Infect. 2017;75:125-131.
    PubMed     Abstract available

    July 2017
  68. VILLAR-HERNANDEZ R, Latorre I, Minguez S, Diaz J, et al
    Use of IFN-gamma and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases.
    J Infect. 2017 Jul 24. pii: S0163-4453(17)30248.
    PubMed     Abstract available

  69. HELLA J, Morrow C, Mhimbira F, Ginsberg S, et al
    Tuberculosis transmission in public locations in Tanzania: a novel approach to studying airborne disease transmission.
    J Infect. 2017 Jul 1. pii: S0163-4453(17)30227.
    PubMed     Abstract available

    June 2017
  70. PEREZ-VELEZ CM, Roya-Pabon CL, Marais BJ
    A systematic approach to diagnosing intra-thoracic tuberculosis in children.
    J Infect. 2017;74 Suppl 1:S74-S83.
    PubMed     Abstract available

  71. OUTHRED AC, Britton PN, Marais BJ
    Drug-Resistant tuberculosis - primary transmission and management.
    J Infect. 2017;74 Suppl 1:S128-S135.
    PubMed     Abstract available

  72. PORMOHAMMAD A, Riahi SM, Nasiri MJ, Fallah F, et al
    Diagnostic test accuracy of adenosine deaminase for tuberculous meningitis: A systematic review and meta-analysis.
    J Infect. 2017;74:545-554.
    PubMed     Abstract available

    May 2017
  73. CLIFFORD V, Tebruegge M, Zufferey C, Germano S, et al
    Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis.
    J Infect. 2017 May 5. pii: S0163-4453(17)30131.
    PubMed     Abstract available

  74. JELJELI M, Guerin-El Khourouj V, Pommelet V, Hormi M, et al
    Cytokine/chemokine secretion for detecting tuberculosis in quantiferon supernatants from HIV+ and HIV- children.
    J Infect. 2017 May 3. pii: S0163-4453(17)30129.

  75. NOUHIN J, Pean P, Madec Y, Chevalier MF, et al
    Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patients.
    J Infect. 2017;74:456-465.
    PubMed     Abstract available

    March 2017
  76. SIMONSEN DF, Farkas DK, Horsburgh CR, Thomsen PR, et al
    Increased risk of active Tuberculosis after Cancer diagnosis.
    J Infect. 2017 Mar 30. pii: S0163-4453(17)30105.

  77. ARNOLD A, Cooke GS, Kon OM, Dedicoat M, et al
    Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008-2014.
    J Infect. 2017;74:260-271.
    PubMed     Abstract available

    February 2017
  78. PARCELL BJ, Jarchow-MacDonald A, Seagar AL, Laurenson I, et al
    Three Year Evaluation of Xpert MTB/RIF in a Low Prevalence Tuberculosis Setting: a Scottish Perspective.
    J Infect. 2017 Feb 22. pii: S0163-4453(17)30054.
    PubMed     Abstract available

    January 2017
  79. PEGORIE M, Denning DW, Welfare W
    Estimating the burden of invasive and serious fungal disease in the United Kingdom.
    J Infect. 2017;74:60-71.
    PubMed     Abstract available

    December 2016
  80. ZETOLA NM, Modongo C, Matsiri O, Tamuhla T, et al
    Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples.
    J Infect. 2016 Dec 22. pii: S0163-4453(16)30336.
    PubMed     Abstract available

  81. WYPLOSZ B, Mougari F, Al Rawi M, Baillon C, et al
    Visualizing viable Mycobacterium tuberculosis in sputum to monitor isolation measures.
    J Infect. 2016 Dec 7. pii: S0163-4453(16)30313.

    November 2016
  82. WON EJ, Choi JH, Cho YN, Jin HM, et al
    Biomarkers for Discrimination between Latent Tuberculosis Infection and Active Tuberculosis Disease.
    J Infect. 2016 Nov 18. pii: S0163-4453(16)30306.
    PubMed     Abstract available

  83. OH J, Choi R, Park HD, Lee H, et al
    Evaluation of vitamin status in patients with pulmonary tuberculosis.
    J Infect. 2016 Nov 10. pii: S0163-4453(16)30280.
    PubMed     Abstract available

    October 2016
  84. KUMAR NP, Moideen K, Sivakumar S, Menon PA, et al
    Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.
    J Infect. 2016 Oct 4. pii: S0163-4453(16)30246.
    PubMed     Abstract available

    April 2016
  85. PARK KH, Lee MS, Kim SM, Park SJ, et al
    Diagnostic usefulness of T-cell based assays for tuberculous meningitis in HIV-uninfected patients.
    J Infect. 2016;72:486-97.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.